Back to search

Boston University

Glycopolymer biomaterials for stimulating and characterizing glial adaptive reprogramming

Abstract

dc:description.abstract

Injury to the central nervous system (CNS) caused by pathophysiological conditions or neural device implantation triggers a complex, multicellular response that is required to repair the damaged neural tissue. Critically, endogenous glial cells, including microglia and astrocytes, must undergo adaptive reprogramming, abandoning homeostatic activities in favor of new, reactive functions. While these functions, including orchestrating immune responses, altering metabolism, and forming astroglial borders, have been increasingly characterized, mechanisms to control or therapeutically modulate these processes remain poorly understood.This thesis has addressed critical gaps in our understanding of how material properties can be used to regulate glial adaptive reprogramming to enhance neural tissue repair and device integration in both CNS injury and implantation contexts. The overarching goal of this work was to design, synthesize, characterize, and implement bioactive, glycan-based materials with tunable chemical, mechanical, and structural properties to dissect the mechanisms of adaptive reprogramming in CNS injury and foreign body response models. Investigation of this knowledge gap led to the development and assessment of three unique biomaterial systems, including: (1) glycan-co-nucleoside hydrogels, which, when tested in models of ischemic stroke, led to enhanced glial-based, neural repair outcomes; (2) thioether-functionalized cellulose coating and films that were oxidation-responsive, tough, biocompatible, and antifouling. Testing in subcutaneous implant models resulted in minimal fibrosis and foreign body response; (3) a RiboTag AAV-loaded biomaterial that enabled astrocyte-border specific transcriptomics. Implementation of this material-enhanced transcriptomic strategy allowed for characterization of reactive astrocytes across time and following drug delivery. This work highlights how the rational design of biomaterials can be used to create tools to dissect and therapeutically manipulate glial adaptive reprogramming. The biomaterial platforms developed in this thesis elucidate structure-function correlations that govern glial reactivity and can serve as a foundation for engineering biomaterials with translational potential for CNS injury repair and neural implant integration.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Biomedical Engineering
Grantor
Boston University
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • DuBois, Eric Michael
Advisor dc:contributor.advisor
  • O’Shea, Timothy M.
ORCID dc:identifier.orcid

Subjects

dc:subject × 7

Rights

dc:rights
Statement dc:rights
  • Attribution 4.0 International
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/52989

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

DuBois, Eric Michael. Glycopolymer biomaterials for stimulating and characterizing glial adaptive reprogramming. doctoral thesis, Boston University, 2026. https://hdl.handle.net/2144/52989